Journal of Biomedical Science,
Journal Year:
2019,
Volume and Issue:
26(1)
Published: May 11, 2019
Nicotinamide
adenine
dinucleotide
(NAD)
is
an
important
coenzyme
that
participates
in
various
energy
metabolism
pathways,
including
glycolysis,
β-oxidation,
and
oxidative
phosphorylation.
Besides,
it
a
required
cofactor
for
post-translational
modifications
such
as
ADP-ribosylation
deacetylation
by
poly
(ADP-ribose)
polymerases
(PARPs)
sirtuins,
respectively.
Thus,
NAD
regulates
metabolism,
DNA
damage
repair,
gene
expression,
stress
response
through
these
enzymes.
Numerous
studies
have
shown
levels
decrease
with
aging
under
disturbed
nutrient
conditions,
obesity.
Additionally,
decline
closely
related
to
the
development
of
metabolic
disorders,
diabetes
fatty
liver
disease.
In
addition,
many
revealed
administration
precursors,
nicotinamide
mononucleotide
(NMN)
riboside
(NR),
efficiently
increase
tissues
prevent
diseases.
These
precursors
are
contained
natural
foods,
cow
milk,
vegetables,
meats.
Therefore,
altered
can
be
practical
target
nutritional
intervention.
Recently,
several
human
clinical
trials
using
been
conducted
investigate
safety,
pharmacokinetics,
efficacy
against
disorders
glucose
intolerance.
this
review,
we
summarize
current
knowledge
on
implications
diseases
discuss
outcomes
recent
trials.
Journal of Biomedical Science,
Journal Year:
2019,
Volume and Issue:
26(1)
Published: May 11, 2019
Nicotinamide
adenine
dinucleotide
(NAD)
is
an
important
coenzyme
that
participates
in
various
energy
metabolism
pathways,
including
glycolysis,
β-oxidation,
and
oxidative
phosphorylation.
Besides,
it
a
required
cofactor
for
post-translational
modifications
such
as
ADP-ribosylation
deacetylation
by
poly
(ADP-ribose)
polymerases
(PARPs)
sirtuins,
respectively.
Thus,
NAD
regulates
metabolism,
DNA
damage
repair,
gene
expression,
stress
response
through
these
enzymes.
Numerous
studies
have
shown
levels
decrease
with
aging
under
disturbed
nutrient
conditions,
obesity.
Additionally,
decline
closely
related
to
the
development
of
metabolic
disorders,
diabetes
fatty
liver
disease.
In
addition,
many
revealed
administration
precursors,
nicotinamide
mononucleotide
(NMN)
riboside
(NR),
efficiently
increase
tissues
prevent
diseases.
These
precursors
are
contained
natural
foods,
cow
milk,
vegetables,
meats.
Therefore,
altered
can
be
practical
target
nutritional
intervention.
Recently,
several
human
clinical
trials
using
been
conducted
investigate
safety,
pharmacokinetics,
efficacy
against
disorders
glucose
intolerance.
this
review,
we
summarize
current
knowledge
on
implications
diseases
discuss
outcomes
recent
trials.